Madison Investments, an investment advisor, released its “Madison Small Cap Fund” fourth-quarter 2024 investor letter. A copy ...

LOS ANGELES, CA / ACCESS Newswire / February 18, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...

Clinical research company Medpace Holdings (NASDAQ:MEDP) in Q4 CY2024, with sales up 7.7% year on year to $536.6 million. On ...

Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results tomorrow after market hours.

What Happened? Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 8.7% in the pre-market session after ...

Equities research analysts at William Blair decreased their Q3 2025 earnings estimates for Medpace in a research report ...

Analysts at William Blair raised their Q1 2025 EPS estimates for shares of Medpace in a research note issued to investors on ...

Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

Good day, ladies and gentlemen, and welcome to the Medpace Fourth Quarter and Full-Year 2024 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers' ...

Medpace Holdings Inc (NASDAQ:MEDP) reported fourth-quarter financial results after the market close on Monday. Here's a ...

Narrow-moat Medpace reported mixed 2024 results. Revenue increased to $2.1 billion, up 11.8% from $1.9 billion in 2023, but the company continues to face challenges from elevated cancellation ...

Medpace expects full-year earnings to be $11.93 to $12.69 per share, with revenue in the range of $2.11 billion to $2.21 billion. This story was generated by Automated Insights ( ...